<DOC>
	<DOCNO>NCT00059930</DOCNO>
	<brief_summary>The purpose study find high dose give safely people liver disease resect . This Phase I study . The goal phase I study find safe dose range base side effect . The drug give vein OXALIPLATIN ( `` Oxali '' ) plus 5-FLUOROURACIL LEUCOVORIN ( `` 5FU '' `` LV '' ) . This systemic chemotherapy , since go whole body . The drug place pump FLOXURIDINE ( FUDR ) DEXAMETHASONE . ( The dexamethasone anti-tumor drug ; help protect healthy liver tissue possible side effect FUDR . ) This regional chemotherapy , since go liver . The researcher study drug know best dos use patient liver resection . We yet know drug work patient liver resection . This study tell u best dos drug give period time .</brief_summary>
	<brief_title>Adjuvant Hepatic Arterial Infusion Combination Chemotherapy Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Floxuridine</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>Subject History histologically confirm colorectal adenocarcinoma metastatic liver clinical radiographic evidence extrahepatic disease . Confirmation diagnosis must perform MSKCC . Potentially completely resectable hepatic metastasis without current evidence metastatic disease . Abdominal pelvic CT scan chest CT xray within 6 week prior registration . ( MRI abdomen may substitute CT abdomen . ) Lab value within 14 day prior registration : WBC ≥ 3.0 K/ul ANC &gt; 1.5 K/ul Platelets ≥ 100 K/ul Total bilirubin ≤ 1.5 mg/dl . Prior chemotherapy acceptable last dose give ≥ 3 week prior registration study . KPS ≥ 60 % Signed informed consent . Subject Prior radiation liver . ( Prior radiation therapy pelvis acceptable complete least 4 week prior registration . ) Active infection , ascites , hepatic encephalopathy Prior oxaliplatin cisplatin HAI FUDR Female patient pregnant lactate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>liver metastasis</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>adenocarcinoma rectum</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
</DOC>